四川科伦药业股份有限公司增持石四药集团(02005)112.8万股 每股作价约3.1港元

Core Insights - Sichuan Kelun Pharmaceutical Co., Ltd. has increased its stake in Stone Four Pharmaceutical Group by acquiring 1.128 million shares at a price of HKD 3.0978 per share, totaling HKD 3.4943 million [1] - Following this acquisition, Sichuan Kelun's total shareholding in Stone Four Pharmaceutical Group has reached approximately 680 million shares, representing a 23.03% ownership stake [1]